HEADER IMMUNE SYSTEM 20-JUN-13 4LAR TITLE CRYSTAL STRUCTURE OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN COMPLEX TITLE 2 WITH AMPHETAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SINGLE CHAIN ANTIBODY FRAGMENT SCFV6H4; COMPND 3 CHAIN: H; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: KM71H; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPICZ-ALPHA KEYWDS METHAMPHETAMINE, ANTI-METHAMPHETAMINE ANTIBODY, THERAPEUTIC ANTIBODY, KEYWDS 2 SCFV, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR R.CELICAL,K.GOKULAN,E.C.PETERSON,K.I.VARUGHESE REVDAT 5 16-OCT-24 4LAR 1 REMARK REVDAT 4 20-SEP-23 4LAR 1 HETSYN REVDAT 3 25-DEC-19 4LAR 1 TITLE COMPND SOURCE JRNL REVDAT 3 2 1 REMARK DBREF SEQRES HELIX REVDAT 3 3 1 SHEET SSBOND SITE ATOM REVDAT 2 17-JUL-19 4LAR 1 REMARK REVDAT 1 11-DEC-13 4LAR 0 JRNL AUTH E.C.PETERSON,R.CELIKEL,K.GOKULAN,K.I.VARUGHESE JRNL TITL STRUCTURAL CHARACTERIZATION OF A THERAPEUTIC JRNL TITL 2 ANTI-METHAMPHETAMINE ANTIBODY FRAGMENT: OLIGOMERIZATION AND JRNL TITL 3 BINDING OF ACTIVE METABOLITES. JRNL REF PLOS ONE V. 8 82690 2013 JRNL REFN ESSN 1932-6203 JRNL PMID 24349338 JRNL DOI 10.1371/JOURNAL.PONE.0082690 REMARK 2 REMARK 2 RESOLUTION. 2.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 3 NUMBER OF REFLECTIONS : 7560 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.293 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 373 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.38 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.45 REMARK 3 REFLECTION IN BIN (WORKING SET) : 377 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 60.80 REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE SET COUNT : 17 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1776 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 55 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.89000 REMARK 3 B22 (A**2) : -2.06000 REMARK 3 B33 (A**2) : -0.76000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.24000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.531 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.359 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.266 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.164 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.832 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1835 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2492 ; 1.865 ; 1.949 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 230 ; 7.111 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 70 ;39.288 ;23.714 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 286 ;19.789 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;20.575 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 267 ; 0.109 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1386 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1149 ; 0.851 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1852 ; 1.588 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 686 ; 2.186 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 640 ; 3.333 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4LAR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JUL-13. REMARK 100 THE DEPOSITION ID IS D_1000080395. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-DEC-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7947 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.380 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.3 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : 0.04000 REMARK 200 FOR THE DATA SET : 24.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 3GK2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.15M SODIUM CITRATE, 0.28M IMIDAZOLE REMARK 280 -MALATE, PH 7.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 287.1K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.61350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY H 117A REMARK 465 GLY H 117B REMARK 465 GLY H 117C REMARK 465 GLY H 117D REMARK 465 SER H 117E REMARK 465 GLY H 117F REMARK 465 GLY H 117G REMARK 465 GLY H 117H REMARK 465 GLY H 117I REMARK 465 ALA H 233 REMARK 465 PRO H 234 REMARK 465 HIS H 235 REMARK 465 HIS H 236 REMARK 465 HIS H 237 REMARK 465 HIS H 238 REMARK 465 HIS H 239 REMARK 465 HIS H 240 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER H 96 O HOH H 401 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER H 15 -18.28 79.03 REMARK 500 SER H 31 179.14 176.72 REMARK 500 SER H 62 -9.70 -53.38 REMARK 500 LYS H 64 -75.95 17.15 REMARK 500 ASP H 72 72.71 -150.20 REMARK 500 ASN H 76 57.43 37.36 REMARK 500 GLU H 88 -13.40 -48.85 REMARK 500 ASP H 102 57.89 -115.87 REMARK 500 TYR H 103 -35.32 -32.78 REMARK 500 THR H 175 -43.15 69.04 REMARK 500 ALA H 208 179.80 175.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1WE L 300 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3GKZ RELATED DB: PDB REMARK 900 SINGLE CHAIN VARIABLE FRAGMENT REMARK 900 RELATED ID: 4LAQ RELATED DB: PDB REMARK 900 RELATED ID: 4LAS RELATED DB: PDB DBREF 4LAR H 1 240 PDB 4LAR 4LAR 1 240 SEQRES 1 H 249 GLU VAL GLN LEU GLN GLU SER GLY PRO SER LEU VAL LYS SEQRES 2 H 249 PRO SER GLN THR LEU SER LEU THR CYS SER VAL THR GLY SEQRES 3 H 249 ASP SER VAL THR SER GLY TYR TRP SER TRP ILE ARG GLN SEQRES 4 H 249 PHE PRO GLY ASN LYS LEU ASP TYR MET GLY TYR ILE SER SEQRES 5 H 249 TYR ARG GLY SER THR TYR TYR ASN PRO SER LEU LYS SER SEQRES 6 H 249 ARG ILE SER ILE THR ARG ASP THR SER LYS ASN GLN VAL SEQRES 7 H 249 TYR LEU GLN LEU LYS SER VAL SER SER GLU ASP THR ALA SEQRES 8 H 249 THR TYR TYR CYS SER TYR PHE ASP SER ASP ASP TYR ALA SEQRES 9 H 249 MET GLU TYR TRP GLY GLN GLY THR SER VAL THR VAL SER SEQRES 10 H 249 GLY GLY GLY GLY SER GLY GLY GLY GLY SER GLY GLY GLY SEQRES 11 H 249 GLY SER GLN ILE VAL LEU THR GLN SER PRO ALA ILE MET SEQRES 12 H 249 SER ALA SER PRO GLY GLU LYS VAL THR LEU THR CYS SER SEQRES 13 H 249 ALA SER SER SER VAL SER SER SER HIS LEU TYR TRP TYR SEQRES 14 H 249 GLN GLN LYS PRO GLY SER SER PRO LYS LEU TRP ILE TYR SEQRES 15 H 249 SER THR SER ASN LEU ALA SER GLY VAL PRO ALA ARG PHE SEQRES 16 H 249 SER GLY SER GLY SER GLY THR SER TYR SER LEU THR ILE SEQRES 17 H 249 SER SER MET GLU ALA GLU ASP ALA ALA SER TYR PHE CYS SEQRES 18 H 249 HIS GLN TRP SER SER PHE PRO PHE THR PHE GLY SER GLY SEQRES 19 H 249 THR LYS LEU GLU ILE LYS ARG ALA PRO HIS HIS HIS HIS SEQRES 20 H 249 HIS HIS HET 1WE H 300 10 HETNAM 1WE (2S)-1-PHENYLPROPAN-2-AMINE HETSYN 1WE DEXTROAMPHETAMINE; D-AMPHETAMINE; DEXAMPHETAMINE; HETSYN 2 1WE DEXEDRINE; DEXTROSTAT FORMUL 2 1WE C9 H13 N FORMUL 3 HOH *55(H2 O) HELIX 1 1 PRO H 41 ASN H 43 5 3 HELIX 2 2 THR H 73 LYS H 75 5 3 HELIX 3 3 SER H 86 THR H 90 5 5 HELIX 4 4 SER H 153 SER H 155 5 3 HELIX 5 5 GLU H 203 ALA H 207 5 5 SHEET 1 A 4 VAL H 2 SER H 7 0 SHEET 2 A 4 LEU H 18 GLY H 26 -1 O THR H 25 N GLN H 3 SHEET 3 A 4 GLN H 77 LEU H 82 -1 O VAL H 78 N CYS H 22 SHEET 4 A 4 ILE H 67 ASP H 72 -1 N THR H 70 O TYR H 79 SHEET 1 B 6 LEU H 11 VAL H 12 0 SHEET 2 B 6 THR H 112 VAL H 116 1 O THR H 115 N VAL H 12 SHEET 3 B 6 ALA H 91 PHE H 98 -1 N TYR H 93 O THR H 112 SHEET 4 B 6 TYR H 33 GLN H 39 -1 N ILE H 37 O TYR H 94 SHEET 5 B 6 LEU H 45 SER H 52 -1 O ASP H 46 N ARG H 38 SHEET 6 B 6 THR H 57 TYR H 59 -1 O TYR H 58 N TYR H 50 SHEET 1 C 4 LEU H 11 VAL H 12 0 SHEET 2 C 4 THR H 112 VAL H 116 1 O THR H 115 N VAL H 12 SHEET 3 C 4 ALA H 91 PHE H 98 -1 N TYR H 93 O THR H 112 SHEET 4 C 4 GLU H 106 TRP H 108 -1 O TYR H 107 N TYR H 97 SHEET 1 D 4 LEU H 127 THR H 128 0 SHEET 2 D 4 VAL H 142 ALA H 148 -1 O SER H 147 N THR H 128 SHEET 3 D 4 SER H 194 ILE H 199 -1 O LEU H 197 N LEU H 144 SHEET 4 D 4 PHE H 186 SER H 191 -1 N SER H 189 O SER H 196 SHEET 1 E 6 ILE H 133 ALA H 136 0 SHEET 2 E 6 THR H 226 ILE H 230 1 O GLU H 229 N MET H 134 SHEET 3 E 6 ALA H 208 GLN H 214 -1 N ALA H 208 O LEU H 228 SHEET 4 E 6 LEU H 157 GLN H 162 -1 N GLN H 162 O SER H 209 SHEET 5 E 6 LYS H 169 TYR H 173 -1 O TRP H 171 N TRP H 159 SHEET 6 E 6 ASN H 177 LEU H 178 -1 O ASN H 177 N TYR H 173 SHEET 1 F 4 ILE H 133 ALA H 136 0 SHEET 2 F 4 THR H 226 ILE H 230 1 O GLU H 229 N MET H 134 SHEET 3 F 4 ALA H 208 GLN H 214 -1 N ALA H 208 O LEU H 228 SHEET 4 F 4 THR H 221 PHE H 222 -1 O THR H 221 N GLN H 214 SSBOND 1 CYS H 22 CYS H 95 1555 1555 2.10 SSBOND 2 CYS H 146 CYS H 212 1555 1555 2.07 CISPEP 1 SER H 130 PRO H 131 0 5.64 CISPEP 2 PHE H 218 PRO H 219 0 -6.58 SITE 1 AC1 5 TYR H 33 SER H 35 GLU H 106 HIS H 213 SITE 2 AC1 5 TRP H 215 CRYST1 34.545 65.227 48.593 90.00 98.70 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028948 0.000000 0.004430 0.00000 SCALE2 0.000000 0.015331 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020819 0.00000